Journal
CURRENT OPINION IN BIOTECHNOLOGY
Volume 78, Issue -, Pages -Publisher
CURRENT BIOLOGY LTD
DOI: 10.1016/j.copbio.2022.102797
Keywords
-
Ask authors/readers for more resources
Allogeneic chimeric antigen-receptor T-cell process flows involve traditional and novel processing steps, starting from donor-derived cells to generate batches for treating multiple patients. Diverse unit operation-process safety considerations need to be taken into account to ensure process safety.
Allogeneic chimeric antigen-receptor T-cell process flows comprise large-scale primary cultures incorporating traditional biologics processing steps such as cell expansion, with novel processing steps such as electroporation. In addition, these process flows begin with donor-derived peripheral blood mononuclear cells and generate single batches of product, which may be used to treat hundreds of patients. The corresponding unit operation-process safety considerations are individually diverse, and in combination are currently unique and rapidly evolving. The use of available regulations and the principles of quality by design are useful in designing appropriate control strategies into the process during development to ensure process safety.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available